Company Announcements Douglas Scientific acquired in January the Smart-DART Platform for portable molecular diagnostics screening from DIAGENTIX. DIAGENTIX continues to have rights to develop and commercialize the platform. In February, Life Technologies assigned IntegenX the rights to distribute Life’s GlobalFiler Express chemistry on IntegenX’s RapidHIT platform. WaferGen announced in March it named Maithreyan Srinivasan, formerly […]
At a time when large exhibitions seem to be declining in attendance and exhibitor participation, Analytica has clearly established itself as a “must-attend event” based on a proven formula for success. The trade fair took place May 10–13 in Munich, Germany. Held at an outstanding modern venue in the heart of Europe, well planned and […]
Company Announcements Swift Biosciences announced in October 2013 the completion of a $7 million Series B financing. In November 2013, RainDance Technologies named BIOKÉ a distributor for its RainDrop Digital PCR Systems in the Netherlands, Belgium, Luxembourg and Germany. BioMérieux selected Life Technologies’ 7500 instrument range as the preferred thermocyclers for its new molecular biological […]
Company Announcements Life Technologies announced in July an agreement to distribute CEERAM’s (the European Centre for Expertise and Research on Microbial Agents) RT-qPCR assays for the detection of Norovirus GI and Norovirus GII, Hepatitis A and the Mengovirus Extraction Control Kit. Under a joint development agreement announced in July, Rheonix will supply its technology to […]
Molecular cytogenetic technologies have become vitally important in the analysis of chromosomes for both diagnostics and research applications. Technologies such as fluorescent in situ hybridization (FISH) and microarrays are replacing traditional karyotyping. FISH uses fluorescent probes that bind to the complementary DNA sequence on a chromosome. The samples are typically placed on a glass slide, […]
Company Announcements RainDance Technologies closed a $20 million Series E financing round in April that included Myriad Genetics as a new strategic equity investor. In April, Co-Diagnostics agreed to acquire from DNA Logix certain technologies for genetic analysis in the clinical, industrial and bio-threat markets. BioFire Diagnostics expanded its financial commitment with Athyrium Opportunities Fund […]
Company Announcements Cepheid 2012 Non-Clinical sales grew 19.3% to $35.2 million, or 11% of total revenues, primarily due to greater shipments of anthrax test cartridges to Northrop Grumman/US Postal Service (USPS). The company agreed to sell the test cartridges and associated materials used in the Biohazard Detection System directly to USPS through the period ending […]
Company Announcements WaferGen Bio-systems exclusively licensed from Rutgers University a patent covering a novel RNA Quality Control technology and entered into a strategic collaboration with RUCDR Infinite Biologics. In December 2012, Seegene announced a licensing agreement with Dupont Nutrition & Health for the use of its technologies in highly multiplexed real-time PCR assays for the […]
The life science instrumentation (LSI) market is the largest technology sector, accounting for about a quarter of the total analytical instruments industry. It encompasses a broad spectrum of technologies grouped into 13 categories. Unlike most other instrument markets, the LSI market is heavily reliant on the aftermarket. Consumables, reagents, kits and other aftermarket products make […]
Company Announcements Idaho Technology changed its name in August to BioFire Diagnostics. In September, BioFire Diagnostics completed a $25 million financing with Athyrium Opportunities Fund. EnviroLogix named John N. Marker, formerly a manufacturing general manager at GE Healthcare, president and CEO in October. RainDance Technologies announced in October a collaboration with Integrated DNA Technologies to […]
Pay Invoice
Latest Blogs
-
Syncell: Advancing Spatial Proteomics
June 30, 2025 3:41 pm
-
SDi Forecasts Growth in Demand for Analytical Instruments 2024–2029
May 29, 2025 1:38 pm
-
NIH Disruptions and Lab Tool Companies: Stocks React
April 30, 2025 1:17 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
